Deutsche Boerse says relocation of euro clearing from London inevitable



By Huw Jones

LONDON, Sept 27 (Reuters) - Euro derivatives clearing was shifting from London to Frankfurt, showing how ending a heavy reliance on Britain after Brexit is feasible, a senior Deutsche Boerse official said on Monday.

The European Union is due to decide by year-end on how to shift clearing in euro denominated swaps to Frankfurt from the London Stock Exchange's LSEG.L LCH arm, which accounts for about 90% of the activity.

"It's not a question of if liquidity moves, but a question of by how much and when," said Philip Simons, global head of fixed income derivatives at Deutsche Boerse's DB1Gn.DE Eurex derivatives arm told the IDX conference in London.

"We have seen very little change," countered LCH head Daniel Maguire.

Britain wants its temporary permission to clear euro swaps for EU customers until June next year made permanent. Brussels says the status quo is unsustainable, though financial firms are opposed to mandatory relocation.

The EU wants direct oversight of trillions of euros in euro clearing, saying it's a financial stability matter, but Maguire said LCH is already directly regulated by the bloc's securities watchdog ESMA.

"Forcibly fragmenting liquidity is really going to increase the financial stability risk rather than decreasing it," Maguire said, adding it would reduce choice and competition and leave customers in the EU with poorer prices and narrower liquidity.

"The debate needs to move - and it is doing - to focus on how can the EU authorities have a say in global markets and have a seat at the table on how they are run," Maguire said.

Emma West, EMEA head of futures & options at Bank of America, said being forced to close positions in London and reopen them elsewhere would cause some market disruption.

Bill Stenning, head of public affairs in Britain at French bank SocGen said access to Britain is needed to offer a full, cost-effective global service to customers given that 75% of euro swaps are traded outside the bloc.

"There are plenty of products available in the UK that are not available in the EU," Stenning said.
Reporting by Huw Jones; Editing by Bernadette Baum

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.